Viewing nowCandesartan Tablets 8 mg (Candesartan Cilexetil)
Candesartan Cilexetil 8mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

MFDS item code 202001794 · Approved 2020.03.16 · Insurance code 646005370
Treatment of essential hypertension and heart failure with left ventricular systolic dysfunction
This medication effectively controls blood pressure in patients with essential hypertension. It is also used for patients with heart failure with impaired left ventricular function who require additional therapy to ACE inhibitors or who do not tolerate ACE inhibitors well. Therefore, it assists in the treatment of hypertension and certain heart failure patients.
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, depending on the patient's tolerability. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
1. Essential hypertension 6) Pediatric patients: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure 3) Pediatric patients: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug or its components, pregnant or nursing women, patients with severe liver disease, and patients with hereditary angioedema should not use this medication. Elderly patients, those with hyperkalemia, liver disease, heart valve disease, and those with impaired kidney function should use this drug cautiously and require regular monitoring. Side effects such as dizziness, back pain, and upper respiratory infections may occur during treatment; in severe cases, symptoms such as hypotension, worsening kidney function, and hyperkalemia may appear, so caution is needed. Especially, heart failure patients or those with weak kidney function should regularly monitor serum potassium and creatinine levels to monitor their condition. This medication may interact with other antihypertensive drugs, diuretics, potassium supplements, etc., so it is essential to consult healthcare personnel. Women who are planning to become pregnant or may be pregnant should not take this medication, and it is also advisable to avoid use while breastfeeding. The safety of this medication has not been established for children and adolescents under 18 years of age, so its use is not recommended. Caution should be taken when driving or operating machinery, as dizziness may occur, and in cases of overdose, hypotension and dizziness may occur, requiring immediate medical attention. This medication should be stored out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. The storage temperature should ideally be maintained between 1 to 30 degrees Celsius. This helps to preserve the medication's effectiveness and safety for a longer period.
Light pink tablet with a convex shape on both sides
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCandesartan Cilexetil 8mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Yuhans Chemical Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Yuhan Corporation

Candesartan Cilexetil 32mg
Tablet · Prescription medication
DKSH Korea Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Jong Kun Dang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
ShinPoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.